ES553642A0 - Procedimiento para ciclizar derivados 2,3-difenilicos de esteres de p-nitrilos. - Google Patents

Procedimiento para ciclizar derivados 2,3-difenilicos de esteres de p-nitrilos.

Info

Publication number
ES553642A0
ES553642A0 ES553642A ES553642A ES553642A0 ES 553642 A0 ES553642 A0 ES 553642A0 ES 553642 A ES553642 A ES 553642A ES 553642 A ES553642 A ES 553642A ES 553642 A0 ES553642 A0 ES 553642A0
Authority
ES
Spain
Prior art keywords
diphenilic
cycling
derivatives
procedure
nitrile esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES553642A
Other languages
English (en)
Other versions
ES8802219A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Laboratoires Hoechst SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Hoechst SA filed Critical Laboratoires Hoechst SA
Publication of ES553642A0 publication Critical patent/ES553642A0/es
Publication of ES8802219A1 publication Critical patent/ES8802219A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES553642A 1985-04-04 1986-04-02 Procedimiento para ciclizar derivados 2,3-difenilicos de esteres de p-nitrilos. Expired ES8802219A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8505123A FR2587339B1 (fr) 1985-04-04 1985-04-04 Nouveaux medicaments constitues par des derives-2,3 ou -3,4 diphenyles des esters g-nitriles ou leurs produits de cyclisation et procedes pour les preparer

Publications (2)

Publication Number Publication Date
ES553642A0 true ES553642A0 (es) 1988-04-16
ES8802219A1 ES8802219A1 (es) 1988-04-16

Family

ID=9317941

Family Applications (4)

Application Number Title Priority Date Filing Date
ES553642A Expired ES8802219A1 (es) 1985-04-04 1986-04-02 Procedimiento para ciclizar derivados 2,3-difenilicos de esteres de p-nitrilos.
ES557625A Expired ES8802490A1 (es) 1985-04-04 1987-07-16 Procedimiento para preparar nuevos derivados 2,3-difenilicos de esteres -8-nitrilos
ES557626A Expired ES8802491A1 (es) 1985-04-04 1987-07-16 Procedimiento para preparar nuevos derivados 3,4-difenilicos de esteres -8-nitrilos
ES557801A Expired ES8802221A1 (es) 1985-04-04 1988-01-15 Procedimiento para ciclizar derivados 2,3-difenilicos de esteres-j-nitrilos

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES557625A Expired ES8802490A1 (es) 1985-04-04 1987-07-16 Procedimiento para preparar nuevos derivados 2,3-difenilicos de esteres -8-nitrilos
ES557626A Expired ES8802491A1 (es) 1985-04-04 1987-07-16 Procedimiento para preparar nuevos derivados 3,4-difenilicos de esteres -8-nitrilos
ES557801A Expired ES8802221A1 (es) 1985-04-04 1988-01-15 Procedimiento para ciclizar derivados 2,3-difenilicos de esteres-j-nitrilos

Country Status (11)

Country Link
US (1) US4785007A (es)
EP (1) EP0203308A2 (es)
JP (1) JPS61229854A (es)
KR (1) KR860008139A (es)
AU (1) AU5561786A (es)
DK (1) DK151586A (es)
ES (4) ES8802219A1 (es)
FR (1) FR2587339B1 (es)
GR (1) GR860891B (es)
PT (1) PT82333B (es)
ZA (1) ZA862458B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI875101L (fi) * 1986-12-03 1988-06-04 Tanabe Seiyaku Co Laktamderivat och preparat innehaollande dessa.
US8278317B2 (en) * 2005-07-22 2012-10-02 Merck Sharp & Dohme Corp. Potassium channel inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE765203C (de) * 1939-08-02 1953-06-01 Ig Farbenindustrie Ag Verfahren zur Herstellung von Piperidonen und Piperidinen
US3468893A (en) * 1966-03-14 1969-09-23 Ciba Geigy Corp 1-substituted-diphenyl-azacycloalkenes
US3956314A (en) * 1970-07-24 1976-05-11 U.C.B., Societe Anonyme Derivatives of 2-pyrrolidinone
US3814771A (en) * 1970-11-19 1974-06-04 T Shen 5-phenyl-2-piperidones and 5-phenyl-2-thiopiperidones
US3718743A (en) * 1970-11-19 1973-02-27 Merck & Co Inc 5-phenyl-2-piperidones and 5-phenyl-2-thiopiperidones in compositions and methods for treating pain, fever and inflammation
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams

Also Published As

Publication number Publication date
AU5561786A (en) 1986-10-09
ZA862458B (en) 1986-11-26
FR2587339B1 (fr) 1988-08-05
ES8802221A1 (es) 1988-04-16
ES8802219A1 (es) 1988-04-16
KR860008139A (ko) 1986-11-12
ES557801A0 (es) 1988-04-16
US4785007A (en) 1988-11-15
DK151586A (da) 1986-10-05
EP0203308A2 (de) 1986-12-03
ES557626A0 (es) 1988-07-01
DK151586D0 (da) 1986-04-03
ES8802490A1 (es) 1988-07-01
ES8802491A1 (es) 1988-07-01
FR2587339A1 (fr) 1987-03-20
GR860891B (en) 1986-08-04
PT82333A (fr) 1986-05-01
JPS61229854A (ja) 1986-10-14
PT82333B (fr) 1988-04-07
ES557625A0 (es) 1988-07-01

Similar Documents

Publication Publication Date Title
ES551924A0 (es) Procedimiento para la preracion de ester-2-(5-cloroquinolin-8-iloxi-5-acetico-alquilico.
NO167034C (no) Fremgangsmaate for fremstilling av 1,6-diklor-1,6-dideoksy-beta-d-fruktofuranosyl-4-kloro-4-dioksy-alfa-galactopyranosid
MX162864B (es) Procedimiento para la preparacion de 2,2,6,6-tetraalquil-4-piperidilaminas
ES556370A0 (es) Procedimiento para la obtencion de acidos 4-quinolon-3-carboxilicos 1,8-puenteados
ES555815A0 (es) Procedimiento de obtencion de derivados de mitomicina.
ES556313A0 (es) Procedimiento para la produccion de gamma-butirolactona.
ES2007557B3 (es) Procedimiento para la preparacion de (2,2)- paraciclofano.
ES554759A0 (es) Procedimiento para la obtencion de 1,3,5-triazintrionas
ES557732A0 (es) Procedimientopara la preparacion de derivados de 2-oxi-4h-3, 1-ebzoxazin-4-ona
FI861378A0 (fi) Anordning foer framstaellning av lakritsband med anvaendning av en mekanisk anordning.
ES554211A0 (es) Procedimiento para la obtencion de acidos 2,3,4,9-tetrahidro-1h-carbazol-1-aceticos sustituidos
NO163453C (no) Fremgangsmaate for fremstilling av sphingosinderivater.
ES557727A0 (es) Procedimiento para la obtencion de acidos 4-quinolon-3-carboxilicos 1,8-puenteados
NO860429L (no) Fremgangsmaate for fremstilling av imidazolyl-indol-derivater.
FI860247A0 (fi) Foerfarande foer framstaellning av 4,4-dialkyl-2-azetidinoner.
ES549378A0 (es) Procedimiento para la preparacion de derivados de 1,3,4-tia-diazol
ES557801A0 (es) Procedimiento para ciclizar derivados 2,3-difenilicos de esteres-j-nitrilos
ES554339A0 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina
ES541910A0 (es) Procedimiento para la fabricacion de derivados de 4,7-dihi- dropirazolo (3,4-b)piridina
FI864790A0 (fi) Foerfarande foer framstaellning av 5-klor- och 5-brom-2-hydroxinikotinsyror.
NO863044D0 (no) Fremgangsmaate for fremstilling av 5,6-dialkoksyantranilsyrer.
NO862493D0 (no) Fremgangsmaate for fremstilling av 2-halonicergolinderivater.
ES549319A0 (es) Procedimiento de obtencion de 2,2-dibromo-3-nitrilo-propio- namida
FI864736A0 (fi) Foerfarande foer framstaellning av 2-substituerade 5-nitroso-4,6-diamino-pyrimidiner.
NO864305D0 (no) Fremgangsmaate for fremstilling av 5-nafthyl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.